148 related articles for article (PubMed ID: 28930209)
1. Potent and Synergistic Extract Combinations from
Ngouana TK; Mbouna CDJ; Kuipou RMT; Tchuenmogne MAT; Zeuko'o EM; Ngouana V; Mallié M; Bertout S; Boyom FF
Medicines (Basel); 2015 Aug; 2(3):220-235. PubMed ID: 28930209
[TBL] [Abstract][Full Text] [Related]
2. Potent antiplasmodial extracts and fractions from Terminalia mantaly and Terminalia superba.
Mbouna CDJ; Kouipou RMT; Keumoe R; Tchokouaha LRY; Fokou PVT; Tali BMT; Sahal D; Boyom FF
Malar J; 2018 Apr; 17(1):142. PubMed ID: 29615047
[TBL] [Abstract][Full Text] [Related]
3. In vitro antimicrobial activity of crude ethanol extracts and fractions of Terminalia catappa and Vitex doniana.
Abiodun OO; Sood S; Osiyemi OA; Agnihotri VK; Gulati A; Ajaiyeoba EO; Singh B
Afr J Med Med Sci; 2015 Mar; 44(1):21-6. PubMed ID: 26548112
[TBL] [Abstract][Full Text] [Related]
4. Antibacterial and Mode of Action of Extracts from Endophytic Fungi Derived from
Mbekou MIK; Dize D; Yimgang VL; Djague F; Toghueo RMK; Sewald N; Lenta BN; Boyom FF
Biomed Res Int; 2021; 2021():6697973. PubMed ID: 34327237
[TBL] [Abstract][Full Text] [Related]
5. Phytochemical Characterization of
Terças AG; Monteiro AS; Moffa EB; Dos Santos JRA; de Sousa EM; Pinto ARB; Costa PCDS; Borges ACR; Torres LMB; Barros Filho AKD; Fernandes ES; Monteiro CA
Front Microbiol; 2017; 8():595. PubMed ID: 28443078
[No Abstract] [Full Text] [Related]
6.
Tchatat Tali MB; Jiatsa Mbouna CD; Yamthe Tchokouaha LR; Tsouh Fokou PV; Tsakem Nangap JM; Keumoe R; Ngoutane Mfopa A; Bakarnga-Via I; Gounoue Kamkumo R; Fekam Boyom F
J Parasitol Res; 2020; 2020():4580526. PubMed ID: 32685201
[TBL] [Abstract][Full Text] [Related]
7. Antifungal and anti-inflammatory potential of eschweilenol C-rich fraction derived from Terminalia fagifolia Mart.
Rodrigues de Araújo A; Iles B; de Melo Nogueira K; Dias JDN; Plácido A; Rodrigues A; Albuquerque P; Silva-Pereira I; Socodatto R; Portugal CC; Relvas JB; Costa Véras LM; Dalmatti Alves Lima FC; Batagin-Neto A; Rolim Medeiros JV; Moreira Nunes PH; Eaton P; de Souza de Almeida Leite JR
J Ethnopharmacol; 2019 Aug; 240():111941. PubMed ID: 31100435
[TBL] [Abstract][Full Text] [Related]
8. Compounds from Terminalia mantaly L. (Combretaceae) Stem Bark Exhibit Potent Inhibition against Some Pathogenic Yeasts and Enzymes of Metabolic Significance.
Tchuente Tchuenmogne MA; Kammalac TN; Gohlke S; Kouipou RMT; Aslan A; Kuzu M; Comakli V; Demirdag R; Ngouela SA; Tsamo E; Sewald N; Lenta BN; Boyom FF
Medicines (Basel); 2017 Jan; 4(1):. PubMed ID: 28930221
[No Abstract] [Full Text] [Related]
9. Terminalia laxiflora and Terminalia brownii contain a broad spectrum of antimycobacterial compounds including ellagitannins, ellagic acid derivatives, triterpenes, fatty acids and fatty alcohols.
Salih EYA; Julkunen-Tiitto R; Lampi AM; Kanninen M; Luukkanen O; Sipi M; Lehtonen M; Vuorela H; Fyhrquist P
J Ethnopharmacol; 2018 Dec; 227():82-96. PubMed ID: 29733942
[TBL] [Abstract][Full Text] [Related]
10. Potential application of extracts from Indian almond (Terminalia catappa Linn.) leaves in Siamese fighting fish (Betta splendens Regan) culture.
Purivirojkul W
Commun Agric Appl Biol Sci; 2012; 77(4):439-48. PubMed ID: 23885412
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory activities of selected Sudanese medicinal plants on Porphyromonas gingivalis and matrix metalloproteinase-9 and isolation of bioactive compounds from Combretum hartmannianum (Schweinf) bark.
Mohieldin EAM; Muddathir AM; Mitsunaga T
BMC Complement Altern Med; 2017 Apr; 17(1):224. PubMed ID: 28427461
[TBL] [Abstract][Full Text] [Related]
12. In vitro antimicrobial activity of extracts and compounds of some selected medicinal plants from Cameroon.
Mbosso EJ; Ngouela S; Nguedia JC; Beng VP; Rohmer M; Tsamo E
J Ethnopharmacol; 2010 Mar; 128(2):476-81. PubMed ID: 20093175
[TBL] [Abstract][Full Text] [Related]
13. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
14. [Antifungal susceptibility profiles of Candida species to triazole: application of new CLSI species-specific clinical breakpoints and epidemiological cutoff values for characterization of antifungal resistance].
Karabıçak N; Alem N
Mikrobiyol Bul; 2016 Jan; 50(1):122-32. PubMed ID: 27058336
[TBL] [Abstract][Full Text] [Related]
15. In vivo antifungal effect of Combretum and Terminalia species extracts on cutaneous wound healing in immunosuppressed rats.
Masoko P; Picard J; Howard RL; Mampuru LJ; Eloff JN
Pharm Biol; 2010 Jun; 48(6):621-32. PubMed ID: 20645734
[TBL] [Abstract][Full Text] [Related]
16. [Comparison of Clinical Laboratory Standards Institute (CLSI) and European Committee on Antimicrobial Susceptibility Testing (EUCAST) broth microdilution methods for determining the susceptibilities of Candida isolates].
Dalyan Cilo B; Topaç T; Ağca H; Sağlam S; Efe K; Ener B
Mikrobiyol Bul; 2018 Jan; 52(1):35-48. PubMed ID: 29642828
[TBL] [Abstract][Full Text] [Related]
17. Anti-quorum Sensing of Terminalia catappa and Murraya koenigii Against Streptococcus mutans.
Ramsundar K; Jain RK; Pitchaipillai SG
Cureus; 2023 Nov; 15(11):e48765. PubMed ID: 38098904
[TBL] [Abstract][Full Text] [Related]
18. Aurifilum, a new fungal genus in the Cryphonectriaceae from Terminalia species in Cameroon.
Begoude AD; Gryzenhout M; Wingfield MJ; Roux J
Antonie Van Leeuwenhoek; 2010 Oct; 98(3):263-78. PubMed ID: 20559872
[TBL] [Abstract][Full Text] [Related]
19. Effect of certain bioactive plant extracts on clinical isolates of beta-lactamase producing methicillin resistant Staphylococcus aureus.
Aqil F; Khan MS; Owais M; Ahmad I
J Basic Microbiol; 2005; 45(2):106-14. PubMed ID: 15812867
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial activity and brine shrimp toxicity of extracts of Terminalia brownii roots and stem.
Mbwambo ZH; Moshi MJ; Masimba PJ; Kapingu MC; Nondo RS
BMC Complement Altern Med; 2007 Mar; 7():9. PubMed ID: 17394672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
